Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Madersbacher

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Cancer Causes & Control : CCC|September 20, 2008
Common genetic polymorphisms of AURKA and prostate cancer riskElisabeth Feik, Andreas Baierl, Stephan Madersbacher, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
BJU International|January 17, 2013
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?Armin Henning, Marlies Wehrberger, Stephan Madersbacher, et al.
European Urology|April 14, 2009
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostateRichard Naspro, Alexander Bachmann, Peter Gilling, et al.
Mutagenesis|February 21, 2013
MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibilityPhilipp Hofer, Julia Zerelles, Andreas Baierl, et al.
The Prostate|April 15, 2003
Reduced circulating androgen bioactivity in patients with prostate cancerTaneli Raivio, Henrikki Santti, Georg Schatzl, et al.
Carcinogenesis|October 12, 2002
Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer riskAndrea Gsur, Martin Preyer, Gerald Haidinger, et al.
The Prostate|July 12, 2002
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly menGeorg Schatzl, Stephan Madersbacher, Andrea Gsur, et al.
The Journal of Urology|March 12, 2003
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancerGeorg Schatzl, Stephan Madersbacher, Andrea Haitel, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Cancer Causes & Control : CCC|September 20, 2008
Common genetic polymorphisms of AURKA and prostate cancer riskElisabeth Feik, Andreas Baierl, Stephan Madersbacher, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
BJU International|January 17, 2013
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?Armin Henning, Marlies Wehrberger, Stephan Madersbacher, et al.
European Urology|April 14, 2009
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostateRichard Naspro, Alexander Bachmann, Peter Gilling, et al.
Mutagenesis|February 21, 2013
MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibilityPhilipp Hofer, Julia Zerelles, Andreas Baierl, et al.
The Prostate|April 15, 2003
Reduced circulating androgen bioactivity in patients with prostate cancerTaneli Raivio, Henrikki Santti, Georg Schatzl, et al.
Carcinogenesis|October 12, 2002
Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer riskAndrea Gsur, Martin Preyer, Gerald Haidinger, et al.
The Prostate|July 12, 2002
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly menGeorg Schatzl, Stephan Madersbacher, Andrea Gsur, et al.
The Journal of Urology|March 12, 2003
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancerGeorg Schatzl, Stephan Madersbacher, Andrea Haitel, et al.
Pageof 19